Tetrandrine attenuates diabetic neuropathic pain by suppressing ferroptosis and inflammation via Alox15 modulation
Archives of Biochemistry and Biophysics · 2026-09 · 783 · 110903
DOI: 10.1016/j.abb.2026.110903 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026-09. Verfasst von Hua Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Management, Hangzhou Third People's Hospital, Hangzhou, 310000, China. Hauptthemen laut MEDLINE: Ferroptosis, Benzylisoquinolines, Arachidonate 15-Lipoxygenase, Diabetic Neuropathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Diabetic neuropathic pain (DNP) is a common, debilitating complication of diabetes with limited disease-modifying therapies. Regulated ferroptosis in neuroimmune signaling that sustains central sensitization. We investigated whether tetrandrine (Tet), a bis-benzyl-isoquinoline alkaloid with anti-inflammatory properties, mitigates DNP by targeting ferroptotic and inflammatory pathways in the spinal cord and investigate the potential molecular mediator. We found that systemic Tet treatment markedly reduced mechanical allodynia in DNP rats and suppressed spinal glial activation and proinflammatory cytokine secretion. RNA-seq revealed Tet-reversed transcriptional changes enriched in immune pathways, with Alox15 among Tet-responsive genes, which involved in ferroptosis. In DNP rat spinal cord, Tet lowered spinal MDA and Fe2+, restored GPX4 and ferritin subunit expression, and reduced Alox15 upregulation. In rat microglial cells (RMCs), Tet rescued Erastin-induced ferroptosis, improved viability, reduced ROS, MDA, Fe2+, cytokine release, and preserved mitochondrial ultrastructure. Forced Alox15 overexpression abolished Tet's cytoprotective effects, reinstating ferroptosis and inflammatory signaling. Collectively, our findings uncover the mechanism that Tet mitigates DNP-associated mechanical allodynia by restraining spinal ferroptosis, with Alox15 acting as a key counter-regulator of Tet's protective action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Management, Hangzhou Third People's Hospital, Hangzhou, 310000, China.
- Department of Anesthesiology and Pain Management, Hangzhou Third People's Hospital, Hangzhou, 310000, China. Electronic address: anesthesiame@163.com.
Zitieren
APA
Zhang, H., He, J., Zhou, J., Xia, J., Du, Z., & Wang, B. (2026). Tetrandrine attenuates diabetic neuropathic pain by suppressing ferroptosis and inflammation via Alox15 modulation. Archives of Biochemistry and Biophysics, 783, 110903. https://doi.org/10.1016/j.abb.2026.110903
Vancouver
Zhang H, He J, Zhou J, Xia J, Du Z, Wang B. Tetrandrine attenuates diabetic neuropathic pain by suppressing ferroptosis and inflammation via Alox15 modulation. Archives of Biochemistry and Biophysics. 2026;783:110903. doi:10.1016/j.abb.2026.110903
BibTeX
@article{Zhang2026,
author = {Zhang, Hua and He, Jie and Zhou, Jie and Xia, Jurong and Du, Zhongju and Wang, Bo},
title = {Tetrandrine attenuates diabetic neuropathic pain by suppressing ferroptosis and inflammation via Alox15 modulation},
journal = {Archives of Biochemistry and Biophysics},
year = {2026},
volume = {783},
pages = {110903},
doi = {10.1016/j.abb.2026.110903}
}
EUVIMED